کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3907409 | 1599307 | 2016 | 15 صفحه PDF | دانلود رایگان |
• Ovarian cancer in pregnancy should be managed by experienced and multidisciplinary team.
• Obstetric outcome is not adversely affected by the management of ovarian cancer.
• The best time for surgery is the second trimester of pregnancy.
• Standard chemotherapy for ovarian cancer can be administered only during the first trimester of pregnancy.
Adnexal masses are diagnosed in 5% pregnancies and pose diagnostic and management challenges. Ultrasound and magnetic resonance imaging (MRI) are the mainstay as an evaluation procedure; surgery is warranted for persistent masses with a diameter of >5 cm and sonographic signs of possible malignancy. Optimal timing for a planned surgery is the second trimester and does not adversely affect neonatal outcome. Laparoscopy is safe in pregnancy. Management for ovarian cancer during pregnancy should be individualised and formulated by a multidisciplinary team in a specialised centre while also considering the patients' wishes to preserve pregnancy. The following options can be considered: (i) induced abortion followed by standard management of ovarian cancer, (ii) pregnancy-preserving surgery followed by chemotherapy, planned delivery and secondary surgical completion or (iii) neoadjuvant chemotherapy followed by surgery during the postpartum period. Standard chemotherapy administered in non-pregnant population can only be used during the first trimester of pregnancy.
Journal: Best Practice & Research Clinical Obstetrics & Gynaecology - Volume 33, May 2016, Pages 58–72